Suppr超能文献

[支气管不可切除性鳞状细胞癌。作为预后因素的免疫状态研究及用卡介苗进行免疫恢复的尝试(作者译)]

[Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].

作者信息

Pouillart P, Palangie T, Huguenin P, Morin P, Gautier H, Baron A, Mathé G, Lededente A, Botto G

出版信息

Nouv Presse Med. 1978 Jan 28;7(4):265-9.

PMID:345229
Abstract

Sixty-six patients with bronchus non resectable squamous cell carcinoma (stage III and 14) entered into a protocol of chemotherapy depending upon their initial immunological status. These patients with (+) skin tests to recall antigens were allocated to a chemotherapy programme; patients with initially (-) skin tests were submitted to a protocol of immunorestauration with B.C.G. After three weeks of B.C.G. applications on scarifications 17 patients out of 31 presented with (+) skin tests and were considered as immunocompetent patients. All the patients then were submitted to chemotherapy protocol. The comparison of different median of survival have demonstrated that immune status appears as the more fundamental prognosis factor; the B.C.G. is able to transitory restore the immunity of the patients without any modification of the tumour progress. The median of survival of patients with initially (+) skin tests was ten months, and only two months for patients with (-) skin tests. The median of survival of patients whom immunity was restored with B.C.G. was nine months. The results of this trial let us to propose new strategy for treatment of these patients.

摘要

66例无法切除的支气管鳞状细胞癌患者(Ⅲ期和14期)根据其初始免疫状态进入化疗方案。这些对回忆抗原皮肤试验呈阳性的患者被分配到化疗方案中;初始皮肤试验呈阴性的患者接受卡介苗免疫恢复方案。在卡介苗划痕接种三周后,31例患者中有17例皮肤试验呈阳性,被视为免疫功能正常的患者。然后所有患者都接受化疗方案。不同生存中位数的比较表明,免疫状态似乎是更重要的预后因素;卡介苗能够暂时恢复患者的免疫力,而不改变肿瘤进展。初始皮肤试验呈阳性的患者生存中位数为10个月,而呈阴性的患者仅为2个月。通过卡介苗恢复免疫力的患者生存中位数为9个月。该试验结果使我们能够为这些患者提出新的治疗策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验